Overall, with respect to cultured cell lines, animal tumor‐bearing models, and clinical human samples, we revealed that USP52 controlled the sensitivity of tumor cells to ferroptosis by stabilizing the xCT protein in a deubiquitinase‐dependent manner, which consequently facilitated BLCA progression. This evidence concerns the gene SLC7A11 and neoplasm.